Acute valproate exposure affects proneural factor expression by increasing FOXO3 in the hippocampus of juvenile mice with a sex-based difference

Neurosci Lett. 2023 May 29:806:137226. doi: 10.1016/j.neulet.2023.137226. Epub 2023 Apr 3.

Abstract

Valproic acid (VPA), an anticonvulsant and mood stabilizer, may affect Notch signaling and mitochondrial function. In a previous study, acute VPA exposure induced increased expression of FOXO3, a transcription factor that shares common targets with pro-neuronal ASCL1. In this study, intraperitoneal acute VPA (400 mg/kg) administration in 4-week-old mice increased and decreased FOXO3 and ASCL1 expression, respectively, in the hippocampus, associated with sex-based differences. Treatment of Foxo3 siRNA increased the mRNA expression levels of Ascl1, Ngn2, Hes6, and Notch1 in PC12 cells. Furthermore, VPA exposure induced significant expression changes of mitochondria-related genes, including COX4 and SIRT1, in hippocampal tissues, associated with sex-based differences. This study suggests that acute VPA exposure differently affects proneural gene expression via FOXO3 induction in the hippocampus based on sex.

Keywords: ASCL1; FOXO3; Hippocampus; Mitochondria; Valproic acid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anticonvulsants* / pharmacology
  • Forkhead Box Protein O3 / metabolism
  • Gene Expression Regulation
  • Hippocampus / metabolism
  • Mice
  • Neurons / metabolism
  • Rats
  • Transcription Factors / metabolism
  • Valproic Acid* / pharmacology

Substances

  • Anticonvulsants
  • Transcription Factors
  • Valproic Acid
  • Forkhead Box Protein O3